Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024

December 15, 2023

https://www.globenewswire.com/news-release/2023/11/13/2779439/0/en/Design-Therapeutics-Reports-Third-Quarter-2023-Financial-Results-and-Plans-for-a-Comprehensive-Portfolio-Update-in-Early-2024.html

Seasoned Biotech Executive Pratik Shah Appointed as Chief Executive Officer to Lead Company Turnaround

Current Cash and Securities of ~$290M Support Extended Five-Year Operating Runway Through 2028

Read more at globenewswire.com

Related news for (DSGN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.